Dr Hope Rugo, Dr Fatima Cardoso, Dr Sandra Swain, and Dr Javier Cortés discuss the current treatment landscape of managing HER2+ metastatic breast cancer.
Rates of hypertensive disorders of pregnancy climbed in the US between 2016 and 2024, with non-Hispanic American Indian or Alaska Native individuals having the highest absolute rates.
Genome editing is moving beyond experimental promise, as a customized therapy for a rare genetic disorder highlights both its clinical potential and the barriers to broader access.
Delays in breast cancer care persist among young women, particularly those with lower incomes, but unexpected survival findings suggest a more complex picture.
A review questions routine approaches to delirium, terminal bleeding, and noisy respiratory secretions, finding limited evidence behind several commonly used interventions.
With significant gaps in safety data on the use of GLP-1 drugs in pregnancy among women with diabetes, experts provide consensus-based guidance on key issues.
A retrospective study found that breast skin radiation exposure was associated with lymphedema risk and that mammographic skin-thickness measurements may help detect the complication.
